1857417-13-0,MFCD28506303
Catalog No.:AA00AMDX

1857417-13-0 | mi503

Pack Size
Purity
Availability
Price(USD)
Quantity
  
10mg
99+%
1 week  
$94.00   $66.00
- +
25mg
99+%
1 week  
$160.00   $112.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00AMDX
Chemical Name:
mi503
CAS Number:
1857417-13-0
Molecular Formula:
C28H27F3N8S
Molecular Weight:
564.6278
MDL Number:
MFCD28506303
SMILES:
N#Cc1cc2c(n1Cc1c[nH]nc1)ccc(c2C)CN1CCC(CC1)Nc1ncnc2c1cc(s2)CC(F)(F)F
Properties
Computed Properties
 
Complexity:
908  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
40  
Hydrogen Bond Acceptor Count:
10  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
7  
XLogP3:
5.8  

Downstream Synthesis Route

[1]Borkin,Dmitry;Pollock,Jonathan;Kempinska,Katarzyna;Purohit,Trupta;Li,Xiaoqin;Wen,Bo;Zhao,Ting;Miao,Hongzhi;Shukla,Shirish;He,Miao;Sun,Duxin;Cierpicki,Tomasz;Grembecka,Jolanta[JournalofMedicinalChemistry,2016,vol.59,#3,p.892-913]

CASUnavailable 
  1857417-13-0 

[1]Borkin,Dmitry;Pollock,Jonathan;Kempinska,Katarzyna;Purohit,Trupta;Li,Xiaoqin;Wen,Bo;Zhao,Ting;Miao,Hongzhi;Shukla,Shirish;He,Miao;Sun,Duxin;Cierpicki,Tomasz;Grembecka,Jolanta[JournalofMedicinalChemistry,2016,vol.59,#3,p.892-913]

[1]Borkin,Dmitry;Pollock,Jonathan;Kempinska,Katarzyna;Purohit,Trupta;Li,Xiaoqin;Wen,Bo;Zhao,Ting;Miao,Hongzhi;Shukla,Shirish;He,Miao;Sun,Duxin;Cierpicki,Tomasz;Grembecka,Jolanta[JournalofMedicinalChemistry,2016,vol.59,#3,p.892-913]

83647-40-9   
1-((1H-pyrazol-4-yl)methyl)-4-methyl-5-((4-((6-(2,2,2-trifluoroethyl)thieno2,3-dpyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1H-indole-2-carbonitrile 

[1]JournalofMedicinalChemistry,2016,vol.59,p.892-913

[1]Borkin,Dmitry;Pollock,Jonathan;Kempinska,Katarzyna;Purohit,Trupta;Li,Xiaoqin;Wen,Bo;Zhao,Ting;Miao,Hongzhi;Shukla,Shirish;He,Miao;Sun,Duxin;Cierpicki,Tomasz;Grembecka,Jolanta[JournalofMedicinalChemistry,2016,vol.59,#3,p.892-913]

Literature

Title: Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo.

Journal: Cancer cell 20150413

Title: Borkin D, et al. Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo. Cancer Cell. 2015 Apr 13;27(4):589-602.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1857417-13-0
Tags:1857417-13-0 Molecular Formula|1857417-13-0 MDL|1857417-13-0 SMILES|1857417-13-0 mi503
Catalog No.: AA00AMDX
1857417-13-0,MFCD28506303
1857417-13-0 | mi503
Pack Size: 10mg
Purity: 99+%
1 week
$94.00 $66.00
Pack Size: 25mg
Purity: 99+%
1 week
$160.00 $112.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00AMDX
Chemical Name: mi503
CAS Number: 1857417-13-0
Molecular Formula: C28H27F3N8S
Molecular Weight: 564.6278
MDL Number: MFCD28506303
SMILES: N#Cc1cc2c(n1Cc1c[nH]nc1)ccc(c2C)CN1CCC(CC1)Nc1ncnc2c1cc(s2)CC(F)(F)F
Properties
Complexity: 908  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 40  
Hydrogen Bond Acceptor Count: 10  
Hydrogen Bond Donor Count: 2  
Rotatable Bond Count: 7  
XLogP3: 5.8  
Downstream Synthesis Route
1709863-43-3    1857417-13-0 

[1]Borkin,Dmitry;Pollock,Jonathan;Kempinska,Katarzyna;Purohit,Trupta;Li,Xiaoqin;Wen,Bo;Zhao,Ting;Miao,Hongzhi;Shukla,Shirish;He,Miao;Sun,Duxin;Cierpicki,Tomasz;Grembecka,Jolanta[JournalofMedicinalChemistry,2016,vol.59,#3,p.892-913]

CASUnavailable 
  1857417-13-0 

[1]Borkin,Dmitry;Pollock,Jonathan;Kempinska,Katarzyna;Purohit,Trupta;Li,Xiaoqin;Wen,Bo;Zhao,Ting;Miao,Hongzhi;Shukla,Shirish;He,Miao;Sun,Duxin;Cierpicki,Tomasz;Grembecka,Jolanta[JournalofMedicinalChemistry,2016,vol.59,#3,p.892-913]

83647-43-2    1857417-13-0 

[1]Borkin,Dmitry;Pollock,Jonathan;Kempinska,Katarzyna;Purohit,Trupta;Li,Xiaoqin;Wen,Bo;Zhao,Ting;Miao,Hongzhi;Shukla,Shirish;He,Miao;Sun,Duxin;Cierpicki,Tomasz;Grembecka,Jolanta[JournalofMedicinalChemistry,2016,vol.59,#3,p.892-913]

83647-40-9   
1-((1H-pyrazol-4-yl)methyl)-4-methyl-5-((4-((6-(2,2,2-trifluoroethyl)thieno2,3-dpyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1H-indole-2-carbonitrile 

[1]JournalofMedicinalChemistry,2016,vol.59,p.892-913

50536-58-8    1857417-13-0 

[1]Borkin,Dmitry;Pollock,Jonathan;Kempinska,Katarzyna;Purohit,Trupta;Li,Xiaoqin;Wen,Bo;Zhao,Ting;Miao,Hongzhi;Shukla,Shirish;He,Miao;Sun,Duxin;Cierpicki,Tomasz;Grembecka,Jolanta[JournalofMedicinalChemistry,2016,vol.59,#3,p.892-913]

Literature fold

Title: Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo.

Journal: Cancer cell20150413

Title: Borkin D, et al. Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo. Cancer Cell. 2015 Apr 13;27(4):589-602.

Building Blocks More >
175599-83-4
175599-83-4
Ethyl 2-amino-3-cyano-4,5,6,7-tetrahydro-1-benzothiophene-4-carboxylate
AA00AMPG | MFCD02679242
163759-49-7
163759-49-7
2'-O-(2-Methoxyethyl)-5-methyluridine
AA00ANC5 | MFCD02682964
1516987-57-7
1516987-57-7
(4-Aminomethyl-phenyl)-pyridin-4-yl-amine
AA00ANLA | MFCD26857757
171919-37-2
171919-37-2
1-Methyl-1h-pyrrolo[2,3-b]pyridine-3-carboxylic acid
AA00AO3M | MFCD15529044
17331-71-4
17331-71-4
BRASSIDIN
AA00AOG3 | MFCD30724991
19311-37-6
19311-37-6
3-Bromotetrahydrofuran
AA00AOOU | MFCD09056777
15981-92-7
15981-92-7
2,3'-Anhydrothymidine
AA00AOZ1 | MFCD00233554
143896-17-7
143896-17-7
M40
AA00AP5A | MFCD00671424
19861-63-3
19861-63-3
5-Amino-2,4-dichlorobenzoic acid
AA00APCO | MFCD05811316
171118-09-5
171118-09-5
Metolachlor ESA Na-salt, Pestanal
AA00APK1 | MFCD11617361
Submit
© 2017 AA BLOCKS, INC. All rights reserved.